The study was designed with the removal of the misinformed corporate advocacy lens from the drug development process
That is not the only aspect of the trial that left out the corporate lense. Funding and control of the trial direction. I believe most of Rett Syndrome came from the Rett foundation with shares being diluted to keep the doors open.
Great job on this article by RAM. These are the real advocates!